Artículos

Olanzapine and sulpiride: a preliminary study of combination/augmentation in patients with treatment-resistant schizophrenia / Sergey Raskin en Journal of Clinical Psychopharmacology, Año 2000 - Vol. 20 - No. 5 (Octubre)

Público ISBD [artículo]  inJournal of Clinical Psychopharmacology > Año 2000 - Vol. 20 - No. 5 (Octubre) . - pp. 500-503 Título : Olanzapine and sulpiride: a preliminary study of combination/augmentation in patients with treatment-resistant schizophrenia Tipo de documento: texto impreso Autores: Sergey Raskin, Autor ; Rimona Durst, Autor ; Gregory Katz, Autor Fecha de publicación: 2023 Artículo en la página: pp. 500-503 Idioma : Inglés (eng) Idioma original : Inglés (eng) Palabras clave: Antipsicóticos, Benzodiazepinas, Farmacoterapia, Pirenzepina, Esquizofrenia. Resumen: Coadministration of olanzapine, an atypical neuroleptic, with sulpiride, a selective D2 antagonist, is suggested as an efficient strategy for treating patients with resistant unremitting schizophrenia. The psychopharmacologic rationale that may account for the enhanced clinical efficacy of combining sulpiride with olanzapine and vice versa is the difference in affinity of the two drugs to brain receptors. Link: ./index.php?lvl=notice_display&id=31163 [artículo] Olanzapine and sulpiride: a preliminary study of combination/augmentation in patients with treatment-resistant schizophrenia [texto impreso] / Sergey Raskin, Autor ; Rimona Durst, Autor ; Gregory Katz, Autor . - 2023 . - pp. 500-503. Idioma : Inglés (eng) Idioma original : Inglés (eng) in Journal of Clinical Psychopharmacology > Año 2000 - Vol. 20 - No. 5 (Octubre) . - pp. 500-503 Palabras clave: Antipsicóticos, Benzodiazepinas, Farmacoterapia, Pirenzepina, Esquizofrenia. Resumen: Coadministration of olanzapine, an atypical neuroleptic, with sulpiride, a selective D2 antagonist, is suggested as an efficient strategy for treating patients with resistant unremitting schizophrenia. The psychopharmacologic rationale that may account for the enhanced clinical efficacy of combining sulpiride with olanzapine and vice versa is the difference in affinity of the two drugs to brain receptors. Link: ./index.php?lvl=notice_display&id=31163

Somatic treatment of psychotic depression: review and recommendations for practice / Jason A. Wheeler Vega en Journal of Clinical Psychopharmacology, Año 2000 - Vol. 20 - No. 5 (Octubre)

Público ISBD [artículo]  inJournal of Clinical Psychopharmacology > Año 2000 - Vol. 20 - No. 5 (Octubre) . - pp. 504-519 Título : Somatic treatment of psychotic depression: review and recommendations for practice Tipo de documento: texto impreso Autores: Jason A. Wheeler Vega, Autor ; Ann M. Mortimer, Autor ; Phyllis Tyson, Autor Fecha de publicación: 2023 Artículo en la página: pp. 504-519 Idioma : Inglés (eng) Idioma original : Inglés (eng) Palabras clave: Antipsicóticos, Trastorno depresivo mayor, Terapia electroconvulsiva, Trastornos psicóticos. Resumen: The diagnosis, classification, and course of psychotic major depression (PMD) is considered with regard to its status as a distinct syndrome. Several factors, especially biological markers, suggest, although as yet do not confirm, that PMD is distinct from nonpsychotic major depression (NPMD), particularly for the purposes of treatment. Link: ./index.php?lvl=notice_display&id=31164 [artículo] Somatic treatment of psychotic depression: review and recommendations for practice [texto impreso] / Jason A. Wheeler Vega, Autor ; Ann M. Mortimer, Autor ; Phyllis Tyson, Autor . - 2023 . - pp. 504-519. Idioma : Inglés (eng) Idioma original : Inglés (eng) in Journal of Clinical Psychopharmacology > Año 2000 - Vol. 20 - No. 5 (Octubre) . - pp. 504-519 Palabras clave: Antipsicóticos, Trastorno depresivo mayor, Terapia electroconvulsiva, Trastornos psicóticos. Resumen: The diagnosis, classification, and course of psychotic major depression (PMD) is considered with regard to its status as a distinct syndrome. Several factors, especially biological markers, suggest, although as yet do not confirm, that PMD is distinct from nonpsychotic major depression (NPMD), particularly for the purposes of treatment. Link: ./index.php?lvl=notice_display&id=31164

Efficacy of divalproex therapy for schizoaffective disorder / Ann M. Bogan en Journal of Clinical Psychopharmacology, Año 2000 - Vol. 20 - No. 5 (Octubre)

Público ISBD [artículo]  inJournal of Clinical Psychopharmacology > Año 2000 - Vol. 20 - No. 5 (Octubre) . - pp. 520-522 Título : Efficacy of divalproex therapy for schizoaffective disorder Tipo de documento: texto impreso Autores: Ann M. Bogan, Autor ; E. Sherwood Brown, Autor ; Suppes, Trisha, Autor Fecha de publicación: 2023 Artículo en la página: pp. 520-522 Idioma : Inglés (eng) Idioma original : Inglés (eng) Palabras clave: Anticonvulsivos, Trastornos psicóticos. Resumen: Schizoaffective disorder is a common, severe, and lifelong illness; however, little is known about the pharmacologic treatment of this mental disorder. Divalproex has proven efficacy in the treatment of bipolar disorder. Therefore, to determine whether divalproex is also effective as adjunctive therapy for schizoaffective disorder, the authors performed a retrospective study of 20 patients in the public mental health system with schizoaffective disorder, bipolar type, who initiated divalproex therapy. Link: ./index.php?lvl=notice_display&id=31165 [artículo] Efficacy of divalproex therapy for schizoaffective disorder [texto impreso] / Ann M. Bogan, Autor ; E. Sherwood Brown, Autor ; Suppes, Trisha, Autor . - 2023 . - pp. 520-522. Idioma : Inglés (eng) Idioma original : Inglés (eng) in Journal of Clinical Psychopharmacology > Año 2000 - Vol. 20 - No. 5 (Octubre) . - pp. 520-522 Palabras clave: Anticonvulsivos, Trastornos psicóticos. Resumen: Schizoaffective disorder is a common, severe, and lifelong illness; however, little is known about the pharmacologic treatment of this mental disorder. Divalproex has proven efficacy in the treatment of bipolar disorder. Therefore, to determine whether divalproex is also effective as adjunctive therapy for schizoaffective disorder, the authors performed a retrospective study of 20 patients in the public mental health system with schizoaffective disorder, bipolar type, who initiated divalproex therapy. Link: ./index.php?lvl=notice_display&id=31165

Early termination of antidepressant drug treatment / Michael Linden en Journal of Clinical Psychopharmacology, Año 2000 - Vol. 20 - No. 5 (Octubre)

Público ISBD [artículo]  inJournal of Clinical Psychopharmacology > Año 2000 - Vol. 20 - No. 5 (Octubre) . - pp. 523-530 Título : Early termination of antidepressant drug treatment Tipo de documento: texto impreso Autores: Michael Linden, Autor ; Holger Gothe, Autor ; Ralf W. Dittmann, Autor Fecha de publicación: 2023 Artículo en la página: pp. 523-530 Idioma : Inglés (eng) Idioma original : Inglés (eng) Palabras clave: Antidepresivos, Trastorno depresivo, Práctica familiar, Fluoxetina, Abandono de pacientes, Psiquiatría Resumen: Guidelines for antidepressant drug therapy recommend continuing treatment for several months, even after recovery. Premature termination of medication is viewed as a significant reason for chronicity in depressive disorders. To study the scope and type of this problem, routine treatment cases must be observed in sufficient numbers. Link: ./index.php?lvl=notice_display&id=31166 [artículo] Early termination of antidepressant drug treatment [texto impreso] / Michael Linden, Autor ; Holger Gothe, Autor ; Ralf W. Dittmann, Autor . - 2023 . - pp. 523-530. Idioma : Inglés (eng) Idioma original : Inglés (eng) in Journal of Clinical Psychopharmacology > Año 2000 - Vol. 20 - No. 5 (Octubre) . - pp. 523-530 Palabras clave: Antidepresivos, Trastorno depresivo, Práctica familiar, Fluoxetina, Abandono de pacientes, Psiquiatría Resumen: Guidelines for antidepressant drug therapy recommend continuing treatment for several months, even after recovery. Premature termination of medication is viewed as a significant reason for chronicity in depressive disorders. To study the scope and type of this problem, routine treatment cases must be observed in sufficient numbers. Link: ./index.php?lvl=notice_display&id=31166

Mirtazapine effects on alertness and sleep in patients as recorded by interactive telecommunication during treatment with different dosing regimens / Fenny S. Radhakishun en Journal of Clinical Psychopharmacology, Año 2000 - Vol. 20 - No. 5 (Octubre)

Público ISBD [artículo]  inJournal of Clinical Psychopharmacology > Año 2000 - Vol. 20 - No. 5 (Octubre) . - pp. 531-537 Título : Mirtazapine effects on alertness and sleep in patients as recorded by interactive telecommunication during treatment with different dosing regimens Tipo de documento: texto impreso Autores: Fenny S. Radhakishun, Autor ; Johannes van den Bos, Autor ; Bas van der Heijden, Autor Fecha de publicación: 2023 Artículo en la página: pp. 531-537 Idioma : Inglés (eng) Idioma original : Inglés (eng) Palabras clave: Antidepresivos tricíclicos, Trastorno depresivo, Mianserin, Mirtazapina, Efectos del sueño, Trastornos de iniciación y mantenimiento del sueño. Resumen: This double-blind study compared mirtazapine's effects on alertness and sleep between parallel groups treated for 2 weeks according to a fixed regimen of 30 mg at bedtime (N = 69) and one that increased in dose from 15 to 30 mg at bedtime after the first week (N = 71). These patients with depression used an interactive telephone/computer system for daily alertness and sleep recordings on self-rating scales before and during treatment. Link: ./index.php?lvl=notice_display&id=31167 [artículo] Mirtazapine effects on alertness and sleep in patients as recorded by interactive telecommunication during treatment with different dosing regimens [texto impreso] / Fenny S. Radhakishun, Autor ; Johannes van den Bos, Autor ; Bas van der Heijden, Autor . - 2023 . - pp. 531-537. Idioma : Inglés (eng) Idioma original : Inglés (eng) in Journal of Clinical Psychopharmacology > Año 2000 - Vol. 20 - No. 5 (Octubre) . - pp. 531-537 Palabras clave: Antidepresivos tricíclicos, Trastorno depresivo, Mianserin, Mirtazapina, Efectos del sueño, Trastornos de iniciación y mantenimiento del sueño. Resumen: This double-blind study compared mirtazapine's effects on alertness and sleep between parallel groups treated for 2 weeks according to a fixed regimen of 30 mg at bedtime (N = 69) and one that increased in dose from 15 to 30 mg at bedtime after the first week (N = 71). These patients with depression used an interactive telephone/computer system for daily alertness and sleep recordings on self-rating scales before and during treatment. Link: ./index.php?lvl=notice_display&id=31167

Lithium augmentation of venlafaxine: an open-label trial / Erik Hoencamp en Journal of Clinical Psychopharmacology, Año 2000 - Vol. 20 - No. 5 (Octubre)

Público ISBD [artículo]  inJournal of Clinical Psychopharmacology > Año 2000 - Vol. 20 - No. 5 (Octubre) . - pp. 538-543 Título : Lithium augmentation of venlafaxine: an open-label trial Tipo de documento: texto impreso Autores: Erik Hoencamp, Autor ; P. M. Judith Haffmans, Autor ; Wim A. Dijken, Autor Fecha de publicación: 2023 Artículo en la página: pp. 538-543 Idioma : Inglés (eng) Idioma original : Inglés (eng) Palabras clave: Antidepresivos de segunda generación, Antimaníacos, Ciclohexanoles, Trastorno depresivo, Farmacoterapia, Litio. Resumen: The authors conducted an open-label study of the efficacy and tolerability of venlafaxine and of lithium augmentation in outpatients with depression who were not responding to venlafaxine. Outpatients aged 18 to 70 years were eligible if they had a minimum baseline score of 16 on the 17-item Hamilton Rating Scale for Depression (HAM-D). Link: ./index.php?lvl=notice_display&id=31168 [artículo] Lithium augmentation of venlafaxine: an open-label trial [texto impreso] / Erik Hoencamp, Autor ; P. M. Judith Haffmans, Autor ; Wim A. Dijken, Autor . - 2023 . - pp. 538-543. Idioma : Inglés (eng) Idioma original : Inglés (eng) in Journal of Clinical Psychopharmacology > Año 2000 - Vol. 20 - No. 5 (Octubre) . - pp. 538-543 Palabras clave: Antidepresivos de segunda generación, Antimaníacos, Ciclohexanoles, Trastorno depresivo, Farmacoterapia, Litio. Resumen: The authors conducted an open-label study of the efficacy and tolerability of venlafaxine and of lithium augmentation in outpatients with depression who were not responding to venlafaxine. Outpatients aged 18 to 70 years were eligible if they had a minimum baseline score of 16 on the 17-item Hamilton Rating Scale for Depression (HAM-D). Link: ./index.php?lvl=notice_display&id=31168

Efficacy of open-label nefazodone treatment in patients with panic disorder / Laszlo A. Papp en Journal of Clinical Psychopharmacology, Año 2000 - Vol. 20 - No. 5 (Octubre)

Público ISBD [artículo]  inJournal of Clinical Psychopharmacology > Año 2000 - Vol. 20 - No. 5 (Octubre) . - pp. 544-546 Título : Efficacy of open-label nefazodone treatment in patients with panic disorder Tipo de documento: texto impreso Autores: Laszlo A. Papp, Autor ; Jeremy D. Coplan, Autor ; Jose M. Martínez, Autor Fecha de publicación: 2023 Artículo en la página: pp. 544-546 Idioma : Inglés (eng) Idioma original : Inglés (eng) Palabras clave: Antidepresivos de segunda generación, Trastorno de pánico, Piperazinas, Triazoles. Resumen: Fifteen patients with panic disorder participated in a 12-week treatment trial with open-label nefazodone. Nefazodone was well-tolerated with minimal side effects; none of the patients reported sexual dysfunction, and only one patient experienced weight gain. Although the response rate was lower than that found with most other antipanic medications, given its favorable side effect profile, nefazodone may be a good alternative for patients apprehensive about potential adverse drug reactions. Link: ./index.php?lvl=notice_display&id=31169 [artículo] Efficacy of open-label nefazodone treatment in patients with panic disorder [texto impreso] / Laszlo A. Papp, Autor ; Jeremy D. Coplan, Autor ; Jose M. Martínez, Autor . - 2023 . - pp. 544-546. Idioma : Inglés (eng) Idioma original : Inglés (eng) in Journal of Clinical Psychopharmacology > Año 2000 - Vol. 20 - No. 5 (Octubre) . - pp. 544-546 Palabras clave: Antidepresivos de segunda generación, Trastorno de pánico, Piperazinas, Triazoles. Resumen: Fifteen patients with panic disorder participated in a 12-week treatment trial with open-label nefazodone. Nefazodone was well-tolerated with minimal side effects; none of the patients reported sexual dysfunction, and only one patient experienced weight gain. Although the response rate was lower than that found with most other antipanic medications, given its favorable side effect profile, nefazodone may be a good alternative for patients apprehensive about potential adverse drug reactions. Link: ./index.php?lvl=notice_display&id=31169

The side effects burden of extended imipramine treatment of panic disorder / Matig Mavissakalian en Journal of Clinical Psychopharmacology, Año 2000 - Vol. 20 - No. 5 (Octubre)

Público ISBD [artículo]  inJournal of Clinical Psychopharmacology > Año 2000 - Vol. 20 - No. 5 (Octubre) . - pp. 547-555 Título : The side effects burden of extended imipramine treatment of panic disorder Tipo de documento: texto impreso Autores: Matig Mavissakalian, Autor ; James Perel, Autor Fecha de publicación: 2023 Artículo en la página: pp. 547-555 Idioma : Inglés (eng) Idioma original : Inglés (eng) Palabras clave: Agorafobia, Antidepresivos, Presión arterial, Frecuencia cardíaca, Imipramina, Trastorno de pánico, Salivación, Disfunción sexual fisiológica, Etapas del sueño, Sudoración. Resumen: In a recent study, the authors gauged the net effectiveness of imipramine to be 53%; that is, of 110 patients having panic disorder with agoraphobia who started a course of imipramine at a fixed, targeted, weight-adjusted dose of 2.25 mg·kg−1·day−1, 59 adhered to the regimen and showed a marked and stable response. Link: ./index.php?lvl=notice_display&id=31170 [artículo] The side effects burden of extended imipramine treatment of panic disorder [texto impreso] / Matig Mavissakalian, Autor ; James Perel, Autor . - 2023 . - pp. 547-555. Idioma : Inglés (eng) Idioma original : Inglés (eng) in Journal of Clinical Psychopharmacology > Año 2000 - Vol. 20 - No. 5 (Octubre) . - pp. 547-555 Palabras clave: Agorafobia, Antidepresivos, Presión arterial, Frecuencia cardíaca, Imipramina, Trastorno de pánico, Salivación, Disfunción sexual fisiológica, Etapas del sueño, Sudoración. Resumen: In a recent study, the authors gauged the net effectiveness of imipramine to be 53%; that is, of 110 patients having panic disorder with agoraphobia who started a course of imipramine at a fixed, targeted, weight-adjusted dose of 2.25 mg·kg−1·day−1, 59 adhered to the regimen and showed a marked and stable response. Link: ./index.php?lvl=notice_display&id=31170

Pindolol augmentation in patients with treatment-resistant panic disorder: a double-blind, placebo-controlled trial / Shmuel Hirschmann en Journal of Clinical Psychopharmacology, Año 2000 - Vol. 20 - No. 5 (Octubre)

Público ISBD [artículo]  inJournal of Clinical Psychopharmacology > Año 2000 - Vol. 20 - No. 5 (Octubre) . - pp. 556-559 Título : Pindolol augmentation in patients with treatment-resistant panic disorder: a double-blind, placebo-controlled trial Tipo de documento: texto impreso Autores: Shmuel Hirschmann, Autor ; Pinhas N. Dannon, Autor ; Iulian Iancu, Autor Fecha de publicación: 2023 Artículo en la página: pp. 556-559 Idioma : Inglés (eng) Idioma original : Inglés (eng) Palabras clave: Ansiolíticos, Farmacoterapia, Fluvoxamina, Trastorno de pánico, Pindolol. Resumen: The objective of this study was to determine the efficacy of pindolol as an augmentor of fluoxetine in treatment-resistant panic disorder (PD). Twenty-five outpatients having PD with or without agoraphobia were included. These patients had not responded to two different trials with antidepressants and an 8-week trial of fluoxetine 20 mg/day. Link: ./index.php?lvl=notice_display&id=31171 [artículo] Pindolol augmentation in patients with treatment-resistant panic disorder: a double-blind, placebo-controlled trial [texto impreso] / Shmuel Hirschmann, Autor ; Pinhas N. Dannon, Autor ; Iulian Iancu, Autor . - 2023 . - pp. 556-559. Idioma : Inglés (eng) Idioma original : Inglés (eng) in Journal of Clinical Psychopharmacology > Año 2000 - Vol. 20 - No. 5 (Octubre) . - pp. 556-559 Palabras clave: Ansiolíticos, Farmacoterapia, Fluvoxamina, Trastorno de pánico, Pindolol. Resumen: The objective of this study was to determine the efficacy of pindolol as an augmentor of fluoxetine in treatment-resistant panic disorder (PD). Twenty-five outpatients having PD with or without agoraphobia were included. These patients had not responded to two different trials with antidepressants and an 8-week trial of fluoxetine 20 mg/day. Link: ./index.php?lvl=notice_display&id=31171

Phenytoin concentration in head hair sections: a method to evaluate the history of drug use / Aristidis M. Tsatsakis en Journal of Clinical Psychopharmacology, Año 2000 - Vol. 20 - No. 5 (Octubre)

Público ISBD [artículo]  inJournal of Clinical Psychopharmacology > Año 2000 - Vol. 20 - No. 5 (Octubre) . - pp. 560-573 Título : Phenytoin concentration in head hair sections: a method to evaluate the history of drug use Tipo de documento: texto impreso Autores: Aristidis M. Tsatsakis, Autor ; Thanasis Psillakis, Autor ; Nikolaos Paritsis, Autor Fecha de publicación: 2023 Artículo en la página: pp. 560-573 Idioma : Inglés (eng) Idioma original : Inglés (eng) Palabras clave: Anticonvulsivos, Inmunoensayo de polarización de fluorescencia, Fenitoína. Resumen: Phenytoin (PHT) levels were determined in sections of head hair taken from 60 patients (34 males and 26 females), aged 5 to 69 years, who were regularly receiving the drug. The hair sectional analysis included dissolution, liquid phase extraction procedures, and immunoassay (Abbott TDx) or high-pressure liquid chromatography (HPLC) analytical techniques. Link: ./index.php?lvl=notice_display&id=31172 [artículo] Phenytoin concentration in head hair sections: a method to evaluate the history of drug use [texto impreso] / Aristidis M. Tsatsakis, Autor ; Thanasis Psillakis, Autor ; Nikolaos Paritsis, Autor . - 2023 . - pp. 560-573. Idioma : Inglés (eng) Idioma original : Inglés (eng) in Journal of Clinical Psychopharmacology > Año 2000 - Vol. 20 - No. 5 (Octubre) . - pp. 560-573 Palabras clave: Anticonvulsivos, Inmunoensayo de polarización de fluorescencia, Fenitoína. Resumen: Phenytoin (PHT) levels were determined in sections of head hair taken from 60 patients (34 males and 26 females), aged 5 to 69 years, who were regularly receiving the drug. The hair sectional analysis included dissolution, liquid phase extraction procedures, and immunoassay (Abbott TDx) or high-pressure liquid chromatography (HPLC) analytical techniques. Link: ./index.php?lvl=notice_display&id=31172